Guardion Health Sciences ... (GHSI)
OTC: GHSI
· Real-Time Price · USD
3.22
0.00 (0.00%)
At close: Mar 06, 2025, 3:00 PM
Guardion Health Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.98M | -4.75M | 424.72K | 372.63K | -1.17M | 533.09K | -8.91M | -1.7M | -1.7M | -2.62M | -14.52M | -3.01M | -4.54M | -2.67M |
Depreciation & Amortization | 4.57K | 4.79K | 4.9K | 4.9K | 4.83K | 4.79K | 302.39K | 312.22K | 317.13K | 317.05K | 330.19K | 357.76K | 160.44K | 59.17K |
Stock-Based Compensation | n/a | 14.79K | 19.6K | 30.14K | n/a | 30.51K | 39.01K | 49.55K | 73.4K | 145.87K | 175.11K | 364.45K | 343.09K | 387.62K |
Other Working Capital | 293.69K | 187.46K | 656.72K | 128.81K | -462.43K | 593.38K | 219.97K | 212.77K | -941.49K | 241.28K | 260.74K | -6.65K | -977.87K | 137.79K |
Other Non-Cash Items | 1.01M | 2.78M | -1.27M | -1.02M | 187.23K | -1.87M | 7.82M | 5.45K | 11.59K | 170.13K | 12.22M | 676.51K | 343.09K | 387.62K |
Deferred Income Tax | n/a | n/a | -19.6K | -30.14K | 68.07K | -30.51K | -39.01K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -112.09K | 700.6K | -474.08K | -123.45K | 573.85K | -549.5K | -577.44K | 42.92K | -1.26M | -95.16K | 401.21K | 187.75K | -828.52K | -197.33K |
Operating Cash Flow | -1.08M | -754.61K | -1.32M | -766.58K | -406.5K | -1.88M | -1.36M | -1.28M | -2.57M | -2.23M | -1.57M | -1.79M | -4.87M | -2.42M |
Capital Expenditures | -5 | n/a | -1 | n/a | -2.14K | -1.65K | n/a | -3.17K | n/a | -2.4K | -74.59K | -75.67K | -1.14K | n/a |
Cash Acquisitions | 16.25M | n/a | 19.93K | n/a | n/a | n/a | n/a | n/a | n/a | 7M | 94.92K | -75.53K | -25.96M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 77.59M | -15.63M | -39.98M | -21.98M | -7.98M | -27.98M | -35M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -82.59M | 25.64M | 41.97M | 14.98M | 9.98M | 27.98M | 28M | n/a |
Other Investing Acitivies | n/a | n/a | 19.93K | n/a | n/a | n/a | n/a | 10.01M | 1.99M | -7M | 76.81K | -27.98M | -32.96M | n/a |
Investing Cash Flow | 16.25M | n/a | 19.93K | n/a | -2.14K | -1.65K | -5M | 10M | 1.99M | -7M | 2.1M | -145.74K | -32.96M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 5.25M | n/a | n/a | -5.25M | 14.98K | n/a | -24.01K | n/a | n/a | -1 | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.95M | n/a | n/a | 57.9K | n/a | -5.25M | 4.31M | n/a | -24.01K | 1.13M | n/a | 1.00 | -1 | 3.57M |
Financial Cash Flow | -5.95M | n/a | -3.64M | 57.9K | n/a | -5.25M | 4.32M | n/a | -24.01K | 9.97M | -1 | n/a | 1.00 | 37.23M |
Net Cash Flow | 9.22M | -754.61K | -1.3M | -708.68K | -408.64K | -7.13M | 2.96M | 8.72M | -607.92K | 738.54K | 530.07K | -1.94M | -37.83M | 34.81M |
Free Cash Flow | -1.08M | -754.61K | -1.32M | -766.58K | -408.64K | -1.88M | -1.36M | -1.29M | -2.57M | -2.23M | -1.64M | -1.87M | -4.87M | -2.42M |